Mediclose Cartridge System
Health Value Creation B.V. (trading as Corporis Medical) · Decision date Oct 14, 2026
What did the FDA decide?
The FDA recorded a substantially equivalent (SESE) decision for the Mediclose Cartridge System, a traditional 510(k) submitted by Health Value Creation B.V., trading as Corporis Medical of Maastricht, NL. The record lists the device under the classification name Endoscopic Tissue Approximation Device, regulation number 876.1500, with primary product code OCW and subsequent codes GCJ and HCF. The application is K262044, received 06/17/2026, with the decision dated 10/14/2026. The review panel was General & Plastic Surgery, while the regulation medical specialty is Gastroenterology/Urology.
SESE means the device was cleared as substantially equivalent to a predicate; it is not a PMA approval. The record states the submission was not reviewed by a third party, was not a combination product, and had no authorized predetermined change control plan. The public record does not describe the cartridge components, materials, predicate device, or any clinical data, so the basis for the equivalence determination remains unknown from these sources.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Gastroenterology, Urology
- Decision date
- Oct 14, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262044
- Regulatory pathway
- 510(k) premarket notification
- Product code
- OCW
- Decision code
- SESE
- Decision date
- Oct 14, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Endoscopic Tissue Approximation Device.
- Product code
- OCW
- FDA device class
- 2
FDA decision timeline
K262044 received
Application receipt date recorded by FDA.
K262044 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Health Value Creation B.V. (trading as Corporis Medical)
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Maastricht
Sources and methodology
- Original FDA record: K262044
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records